JCRB1075.0 IM95
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1075.0 | Cell Name | IM95 |
---|---|---|---|
Profile | Human gastric cancer cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 63 |
Identity | available | Tissue for Primary Cancer | stomach |
Case history | moderately differentiated adenocarcinoma of stomach | Metastasis | |
Tissue Metastasized | Genetics | Modal chromosome number = 46. | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | Td=25 hrs. CEA related antigen observed. HGF production and tumorigenesity is maintained in the cell line. |
Classify | tumor | Established by | Iwai,Y. & Matsuda,M. |
Registered by | Iwai,M. | Regulation for Distribution | |
Comment | Year | 2003 | |
Medium | Dulbecco's modified Eagle's medium(4.5g/L glucose) with 10% fetal bovine serum and 10mg/L insulin. | Methods for Passages | Cells were harvested after the treatment with 0.3% trypsin and 0.03% EDTA. |
Cell Number on Passage | Race | Japanese | |
CO2 Conc. | 5 % | Tissue Sampling | stomach |
Tissue Type | stomach cancer |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:14609362 | Cloning of a cancer cell-producing hepatocyte growth factor, vascular endothelial growth factor, and interleukin-8 from gastric cancer cells. Iwai M,Matsuda M,Iwai Y In Vitro Cell Dev Biol Anim. 2003 Jul-Aug;39(7):288-90 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | JCRB1075.0 | Cell Name | |
---|---|---|---|
LOT No. | 10132009 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 4.5 g/L glucose (high glucose) 10 ug/ml insulin and 10% fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 3.3 - 4.6 x 10^5 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | approx. 46 hrs | Cell Number in Vial (cells/1ml) | 4.3 x 10^6 |
Viability at cell freezing (%) | 94.0 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:9,11 D13S317:10,12 D7S820:9.3,10.3 D16S539:9,10 VWA:17,18,19 TH01:6,10 AM:X TPOX:8,10 CSF1PO:11 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM (high glucose) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1075.0 | Cell Name | |
---|---|---|---|
LOT No. | 11162005 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium (high glucose; 4.5 g/L) with 10 ug/ml insulin and 10% fetal bovine serum (FBS lot; GIBCO 4218333S) | Temperature | 37 C |
Cell Density at Seeding | 4 - 8 x 10^5 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | approx. 1.2 days | Cell Number in Vial (cells/1ml) | 10.0 x 10^6 |
Viability at cell freezing (%) | 96 | Antibiotics Used | free |
Passage Number | Unknown (P7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1075.0 | Cell Name | IM95 |
---|---|---|---|
LOT No. | 09302016 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium (4.5g/L glucose) with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) and 10 mg/L insulin. | Temperature | 37 C |
Cell Density at Seeding | 0.7 - 1.6 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 35 hrs. | Cell Number in Vial (cells/1ml) | 3.4 x 10^6 |
Viability at cell freezing (%) | 76 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM (high glucose) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 76 | Additional information |
Cell No. | JCRB1075.0 | Cell Name | IM95 |
---|---|---|---|
LOT No. | 03302021 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium (high glucose) with 10 mg/L insulin and 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 0.5 - 1.0 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 46 hrs | Cell Number in Vial (cells/1ml) | 3.4 x 10^6 |
Viability at cell freezing (%) | 80 | Antibiotics Used | free |
Passage Number | Unknown (6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 78 | Additional information |